U.S., May 15 -- ClinicalTrials.gov registry received information related to the study (NCT06969664) titled 'A Trial of SHR7280 in Healthy Subjects' on May 06.
Brief Summary: The study is being conducted to evaluate the effect of high-fat meal on pharmacokinetics of SHR7280 after oral administration and the effect of SHR7280 on QT interval at low and high doses in healthy Chinese volunteers.
Study Start Date: May, 2025
Study Type: INTERVENTIONAL
Condition:
Endometriosis
Uterine Fibroids
Assisted Reproduction
Intervention:
DRUG: SHR7280 Tablet
Oral SHR7280 tablet.
DRUG: SHR7280 Placebo Tablet
Oral SHR7280 placebo tablet.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Disclaimer: Curated by HT S...